Neurological diseases

We are a therapeutically focussed CRO devoted to executing clinical trials for Neurological diseases in the most effective manner possible. We put science first, and it shows in every trial.

We approach every study with a mindset focused on solving clients’ challenges with tailored solutions and expertise specific to our Neurological diseases focus areas:

Meet our scientific leaders for Neurological diseases trials

Prof. dr. Leonard van den Berg, neurologist at University Medical Centre (UMC) Utrecht and ALS Centrum. He is experienced in conducting global ALS trials, established the prominent TRICALS site network, and is chair of the European Network for the Cure of ALS.

Meet our scientific leaders for Neurological diseases trials

Prof. dr. Anne Schilder, Ear Institute at University College London (UCL) senior investigator and leader of NIHR UCLH Biomedical Research Centre’s programme for translational hearing. She is a world leader in ENT research.

Meet our scientific leaders for Neurological diseases trials

Prof. dr. Eugen Trinka, chair of the neurology department at Paracelsus Medical University Salzburg and the Austrian Society of Neurology’s president-elect.

Meet our scientific leaders for Neurological diseases trials

Professor John Harrison, Chief Scientific Officer at Scottish Brain Sciences, is a renowned cognition expert with 25 years of experience in aiding over 80 CNS drug development organizations. His contributions include developing the Neuropsychological Test Battery for Alzheimer’s studies and playing a pivotal role in Brintellix’s development and registration. As an Associate Professor at AUmc Alzheimer Center and Visiting Professor at King’s College London, he holds Chartered Psychologist status and has authored over 100 books and scientific articles.

Meet our scientific leaders for Neurological diseases trials

Dr. Cris Lanting, clinical physicist-audiologist, as well as a paediatric audiologist at Radboud University Medical Center (UMC).

Meet our scientific leaders for Neurological diseases trials

Dr. Jort Vijverberg, a neurologist at the Brain Research Center and a senior researcher at Alzheimercentrum Amsterdam. He has been the principal investigator on many Alzheimer’s clinical trials and consults with the pharmaceutical industry.

Meet our scientific leaders for Neurological diseases trials

Professor of Cognitive Health at Oxford University, the Director of Dementias Platform UK, and the Director of the BrainWaves Study of Adolescent Wellbeing and Mental Health. An expert on brain health and the use of big data in medical research, Professor Gallacher holds a visiting professorship at Imperial College London and an honorary professorship at the University of Hong Kong. He is the Principal Investigator for the Caerphilly Prospective Study (CaPS).

Meet our scientific leaders for Neurological diseases trials

Renowned researcher in Neurodegenerative diseases, particularly dementia. His work focuses on understanding vascular contributions to dementia and developing novel therapies. With over two decades of experience, Prof. Hainsworth has published extensively and presented his findings internationally, contributing significantly to the field.

Meet our scientific leaders for Neurological diseases trials

Professor Dag Aarsland is a renowned expert in neurodegenerative diseases, specializing in dementia and Parkinson’s disease. He holds a professorship in Old Age Psychiatry at King’s College London and leads the Centre for Age-Related Medicine at Stavanger University Hospital in Norway. As chair in the European Dementia with Lewy Bodies Consortium (E-DLB), he advances crucial research in this field. With numerous publications and research grants, Professor Aarsland is dedicated to improving diagnosis, treatment, and care for patients with cognitive impairments.

Meet our scientific leaders for Neurological diseases trials

Dr. Marieke Niesters is an experienced anesthesiologist and pain specialist at Leiden University Medical Center. With a focus on innovative approaches to pain management, her work integrates cutting-edge research and clinical practice to improve patient outcomes. Dr. Niesters is dedicated to advancing the understanding and treatment of chronic pain, contributing to both academic research and patient care.

Highlighted trials

Scientific networks

How we operate

Brain Clinical is our proprietary network for Neurological diseases trials, providing experienced investigators and sites for Neurological diseases clinical trials.

Partnerships

Who we work with

The Brain Research Center is a specialised team of doctors, nurses, and neuropsychologists who are focused on client needs. They have extensive experience conducting clinical trials and have connections to innovative drug developers around the globe.

TRICALS, the largest European research initiative to find a cure for ALS, includes 48 top research centres in 16 countries. They are highly experienced in this area, providing efficient trial design and expert study oversight.

European Collaboration for Epilepsy Trials (ECET) is a group of expert scientists collaborating inside the Epilepsy Alliance Europe framework. They help provide access to epilepsy-focused centres and specialists.

Dementia Forum UK provides a vital platform for collaboration and innovation in addressing the challenges of dementia.

The European DLB consortium (E-DLB) is a multicenter and global effort concieved by leaders from the contributing centers and leading scientists in different areas of DLB research.

Success stories

Proven track record

We leverage our unique triangle of Science, Networks, and Operational excellence to run efficient trials across our Neurological diseases areas of expertise. A prime example is the SAPHIR study.

In the SAPHIR study, we helped the Sponsor fine-tune their protocol and identify specialised sites to overcome recruitment challenges. We ultimately helped them find 120 patients at 24 sites and streamline their project’s path to completion.

Related webinars

Webinars
Neurological diseases, Alzheimer's
30-06-2025

Webinar – Boosting patient enrolment and retention in clinical trials: Expert Insights & Tips

On June 30, at 16.00 CEST, we will present the webinar: Boosting patient enrolment and retention in clinical trials: Expert Insights & TipsJoin us for an interactive discussion with experts who will draw upon recent cardiology and neurolog...

Webinars
Neurological diseases, Alzheimer's
06-05-2025

Webinar – The role of EEG in dementia trials

On May 6th, 2025, we will organised the webinar: The role of EEG in dementia trials During this webinar, our speakers Pieter van Mierlo, Dr. Willem de Haan and host Lieza Exalto will explore the following topics:Practical aspects and resti...

Webinars
Cardio-Metabolic and Renal Diseases, Neurological diseases, ALS
26-11-2024

Webinar – Time to event trial designs in ALS: How useful are they?

On NOVEMBER 26th, 2024, we organised the webinar: Time to event trial designs in ALS: How useful are they? During this webinar, our speakers Ruben van Eijk, Lotte Smets, Jordi van Unnik and host Lieza Exalto explored the following topics:A...